CLINICAL DIRECTOR SOLUTIONS LTD

Company Registration Number:
07155983 (England and Wales)

Unaudited abridged accounts for the year ended 28 February 2026

Period of accounts

Start date: 01 March 2025

End date: 28 February 2026

CLINICAL DIRECTOR SOLUTIONS LTD

Contents of the Financial Statements

for the Period Ended 28 February 2026

Balance sheet
Notes

CLINICAL DIRECTOR SOLUTIONS LTD

Balance sheet

As at 28 February 2026


Notes
2026
2025


£
£
Fixed assets
Tangible assets: 3 10,104 13,472
Total fixed assets: 10,104 13,472
Current assets
Debtors:   8,614 8,614
Cash at bank and in hand: 434,760 414,107
Total current assets: 443,374 422,721
Creditors: amounts falling due within one year: 4 (95,102) (92,392)
Net current assets (liabilities): 348,272 330,329
Total assets less current liabilities: 358,376 343,801
Total net assets (liabilities): 358,376 343,801
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 358,375 343,800
Shareholders funds: 358,376 343,801

The notes form part of these financial statements

CLINICAL DIRECTOR SOLUTIONS LTD

Balance sheet statements

For the year ending 28 February 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 15 July 2026
and signed on behalf of the board by:

Name: Jane Woodington
Status: Director

The notes form part of these financial statements

CLINICAL DIRECTOR SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 28 February 2026

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

CLINICAL DIRECTOR SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 28 February 2026

2. Employees

2026 2025
Average number of employees during the period 1 1

CLINICAL DIRECTOR SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 28 February 2026

3. Tangible Assets

Total
Cost £
At 01 March 2025 13,472
At 28 February 2026 13,472
Depreciation
At 01 March 2025 0
Charge for year 3,368
At 28 February 2026 3,368
Net book value
At 28 February 2026 10,104
At 28 February 2025 13,472

CLINICAL DIRECTOR SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 28 February 2026

4. Creditors: amounts falling due within one year note

95102

CLINICAL DIRECTOR SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 28 February 2026

5. Loans to directors

Name of director receiving advance or credit: Jane Woodington
Description of the loan: Directors loan account
£
Balance at 01 March 2025 22,473
Balance at 28 February 2026 22,473